Evidence map›Paper›PMID 42711733›Full record

ArticleDigestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society2026

Diagnostic Performance and Reproducibility of Chromoendoscopic Classification (FOCUS Classification: Flat-Type Dysplasia Optical Assessment by Chromoendoscopy in Ulcerative ColitiS) for Flat-Type Dysplasia in Ulcerative Colitis-Associated Neoplasia.

Kaoru Takabayashi, Shoma Murata, Motoki Sasaki, Kurato Miyazaki, Teppei Masunaga, Kumiko Kirita, Mari Mizutani, Yusuke Yoshimatsu, Yusaku Takatori, Teppei Akimoto and 14 more

Abstract read
In one paragraph

Article in Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Kaoru TakabayashiCenter for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0002-4891-8246
Shoma MurataDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Motoki SasakiDivision of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, Tokyo, Japan.
Kurato MiyazakiCenter for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine, Tokyo, Japan.
Teppei MasunagaDivision of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0002-3968-0969
Kumiko KiritaDivision of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, Tokyo, Japan.
Mari MizutaniCenter for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine, Tokyo, Japan.
Yusuke YoshimatsuDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Yusaku TakatoriCenter for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine, Tokyo, Japan.
Teppei AkimotoDivision of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0002-7472-5210
Hiroki KiyoharaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0001-6315-3782
Shinya SugimotoDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0002-1560-1605
Shintaro KawasakiCenter for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0009-0007-9758-0118
Yohei MikamiDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0001-5104-4415
Noriko MatsuuraDivision of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, Tokyo, Japan.
Atsushi NakayamaDivision of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0001-6487-504X
Tomohisa SujinoDepartment of Multidimensional Analysis of Gastrointestinal Biology, Sakaguchi Laboratory, Keio University School of Medicine, Tokyo, Japan.
Yasuhiro ItoDivision of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, Tokyo, Japan.
Kazuhiro YamanoiDepartment of Pathology, Keio University School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0002-5361-8053
Shigeki SekineDepartment of Pathology, Keio University School of Medicine, Tokyo, Japan.
Yasushi IwaoCenter for Preventive Medicine, Keio University School of Medicine, Tokyo, Japan.
Naohisa YahagiDivision of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, Tokyo, Japan.
Takanori KanaiDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Motohiko KatoCenter for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0002-7579-1316

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesUlcerative colitis-associated neoplasia (UCAN) often presents as flat-type dysplasia that is difficult to characterize endoscopically. We developed a FOCUS (Flat-type dysplasia Optical assessment by Chromoendoscopy in Ulcerative colitiS) classification and evaluated its diagnostic performance and reproducibility.

methodsThis single-center retrospective study included 33 UCAN lesions from 26 patients. Prospectively recorded FOCUS classifications at 230 biopsy sites were compared with histopathology. Chromoendoscopic patterns were categorized as Type I ("suggestive of non-dysplasia,"), Type II ("suggestive of dysplasia with low confidence"), or Type III ("suggestive of dysplasia with high confidence"). Diagnostic performance was assessed using two prespecified thresholds: Types II/III versus Type I and Type III versus Types I/II. Eight endoscopists independently classified all images; interobserver and intraobserver agreement were assessed using Fleiss' and Cohen's κ, respectively.

resultsThe dysplasia-bearing rate increased stepwise from Type I to Type III (Type I 15.5%, Type II 58.3%, Type III 81.8%). Using the primary threshold, sensitivity was 82.0%, and specificity 75.4% (positive likelihood ratio 3.33; negative likelihood ratio 0.24). Interobserver agreement for the three-category classification was moderate to substantial (Fleiss' κ 0.629; 95% CI 0.545-0.712), and median intraobserver agreement was substantial (Cohen's κ 0.738).

conclusionsThe FOCUS classification provides clinically meaningful risk stratification for flat-type dysplasia in a high-risk UCAN cohort, with acceptable interobserver and intraobserver reproducibility.

Indexed as

Colitis-Associated NeoplasmsColitis, UlcerativeColonoscopyAdultAgedBiopsyColoring AgentsFemaleHumansMaleMiddle AgedReproducibility of ResultsRetrospective StudiesColoring Agentschromoendoscopyflat‐type dysplasiaindigo carmineinterobserver agreementulcerative colitis–associated neoplasia

Identifiers

PMID42711733
PMCPMC13554287

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.